PPARβ/δ agonist GW0742 promotes the activation of PPARβ/δ ligand to reduce the occurrence of HCC in HBV transgenic mice via inhibiting steatosis and proliferation and inducing apoptosis.106. Here, PPARD is linked to steatosis.